1786 — Scivision Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- TWD8.82bn
- TWD8.13bn
- TWD712.99m
- 93
- 18
- 97
- 84
Annual cashflow statement for Scivision Biotech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 134 | 152 | 116 | 174 | 210 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 9.07 | 0.604 | 5.45 | -35.7 | -11.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 46.5 | -41.9 | -76 | -21.7 | 10.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 204 | 126 | 98.5 | 178 | 272 |
| Capital Expenditures | -202 | -66.8 | -25.8 | -15 | -14.7 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -44.4 | 87.2 | -51.2 | 64.6 | -199 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -246 | 20.4 | -77 | 49.6 | -213 |
| Financing Cash Flow Items | — | — | — | 0.006 | 0 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.18 | -80.5 | 240 | -300 | -135 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -37.9 | 66.3 | 262 | -71.9 | -75.9 |